Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-01-19
1998-03-24
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514456, 546196, 549398, 549404, 549407, C07D31102, A61K 3135, A61K 31335
Patent
active
057313245
ABSTRACT:
This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, benzopyran, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.
REFERENCES:
Ellis, G.P., et al., Journal of Medicinal Chemistry, 1978, vol. 21, No. 11, "Benzopyrones. 14. Synthesis and Antiallergic Properties of Some N-Tetrazolylcarbosamides And Related Compounds".
Fisher Matthew J.
Happ Anne Marie
Jakubowski Joseph A.
Kinnick Michael Dean
Kline Allen D.
Davis Zinna Northington
Eli Lilly and Company
LandOfFree
Glycoprotein IIb/IIIa antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycoprotein IIb/IIIa antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycoprotein IIb/IIIa antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2289208